๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations

โœ Scribed by V.N.P. Le; E. Robins; M.P. Flament


Book ID
116438574
Publisher
Elsevier Science
Year
2012
Tongue
French
Weight
528 KB
Volume
80
Category
Article
ISSN
0939-6411

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Dry powder formulations for inhalation o
โœ Darragh Murnane; Gary P. Martin; Christopher Marriott ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 307 KB

Direct crystallization of active pharmaceutical ingredient (API) particles in the inhalable size range of 1-6 microm may overcome surface energization resulting from micronization. The aerosolization of fluticasone propionate (FP) and salmeterol xinafoate (SX) microcrystals produced by aqueous cryst